The diagnosis and classification of plasma cell dyscrasias
|
|
- Madison Harris
- 5 years ago
- Views:
Transcription
1 Quantitation of Plasma Cells in Bone Marrow Aspirates by Flow Cytometric Analysis Compared With Morphologic Assessment Kristi J. Smock, MD; Sherrie L. Perkins, MD, PhD; David W. Bahler, MD, PhD Context. Accurate quantitation of bone marrow plasma cells is an important component in the diagnosis and posttreatment assessment of plasma cell dyscrasias. Although flow cytometry is sometimes used for this purpose and can rapidly evaluate many cells, the accuracy of flow-based plasma cell quantitation compared with morphologic assessment (currently the gold standard) is uncertain as direct comparison studies have not been previously reported. Objective. To determine how percentages of plasma cells in diagnostic aspirate smears quantitated by morphologic assessment relate to percentages of plasma cells quantified by flow cytometry. Design. Thirty bone marrow cases with 10% or more plasma cells and leukemia/lymphoma flow cytometry immunophenotyping studies were identified from our hematopathology database. The Wright-stained aspirate smears, marrow biopsy sections, and flow cytometry histograms were reviewed. Results. Morphologically determined plasma cell percentages from the diagnostic aspirate smears were consistently higher than those determined by flow cytometry. Much of this difference appeared to be related to differences in sample quality. However, the cellular processing involved in performing flow cytometry also appeared to reduce plasma cell percentages in many cases. Conclusions. This study helps define the limitations of flow cytometry for quantitating plasma cell loads in marrow aspirate specimens that may significantly affect the diagnosis or assessment of treatment response. (Arch Pathol Lab Med. 2007;131: ) The diagnosis and classification of plasma cell dyscrasias typically require quantitation of plasma cell numbers, along with correlation of clinical, radiographic, laboratory, and pathologic findings. 1 For example, a diagnosis of multiple myeloma involves application of both major and minor criteria. The major criteria include greater than 30% bone marrow plasma cells, histologically confirmed plasmacytoma, or identification of a monoclonal immunoglobulin component (M-spike) in the serum or urine (IgG 3.5 g/dl or IgA 2.0 g/dl). Minor criteria include 10% to 30% marrow plasma cells the presence of an M-spike at levels less than those of major criteria, lytic bone lesions, or a decrease in normal serum immunoglobulin levels ( 50% of normal). Quantitation of plasma cells is also important in assessing treatment responses. Morphologic evaluation of bone marrow specimens is the most common method for quantitating plasma cells for workup of plasma cell dyscrasias and is considered to be the gold standard. 2 Although neoplastic plasma cells are usually straightforward to identify in aspirate smears Accepted for publication November 29, From the Department of Pathology, University of Utah, Salt Lake City. The authors have no relevant financial interest in the products or companies described in this article. A poster (No. 1082) was presented at the 2006 United States and Canadian Academy of Pathology meeting, Atlanta, Ga, February 14, Reprints: David W. Bahler, MD, PhD, Department of Pathology, University of Utah Medical Center, Salt Lake City, UT ( dhb10@utah.edu). and typically resemble normal plasma cells, they may also demonstrate a range of maturation and structures, including blastic, multinucleated, pleomorphic, or anaplastic forms. 1 Both aspirate smears and trephine biopsy sections are often evaluated because neoplastic plasma cell infiltrates may be patchy and localized in some cases. 3 For this reason, immunohistochemical staining of biopsy sections using antibodies against and light chains or CD138, which are specific plasma cell markers, may be necessary for accurate plasma cell quantitation and assessment of plasma cell distribution or growth patterns. 4,5 Flow cytometric immunophenotyping is commonly used as an adjunct to morphologic analysis for evaluation of plasma cell dyscrasias. 6 8 Advantages of this method include the ability to identify small numbers of plasma cells, demonstration of monoclonality, identification of aberrant antigen expression or abnormal expression levels, and rapid turnaround time. In addition, flow cytometry can also often distinguish normal and neoplastic plasma cells on the basis of the differential expression of CD45, CD56, and other markers. 8,9 Despite having certain advantages over morphologic analysis, the accuracy of flow cytometric immunophenotyping for quantitating plasma cell percentages is unknown because comparison studies for morphologic evaluation of diagnostic aspirate smears have not been previously reported. In this study, we compared plasma cell percentages determined by multiparameter flow cytometry and morphologic analysis in 30 bone marrow specimens from patients with plasma cell dyscrasias to determine the accuracy of Arch Pathol Lab Med Vol 131, June 2007 Flow Cytometric Plasma Cell Quantitation Smock et al 951
2 flow cytometry in identifying and quantifying neoplastic plasma cells. In most cases, the percentages of plasma cells quantitated by flow cytometry were markedly lower than those determined by morphologic analysis. MATERIALS AND METHODS Case Selection and Demographic Characteristics The ARUP Laboratories flow cytometry and hematopathology databases were searched for recent bone marrow cases submitted for both morphologic review and leukemia/lymphoma phenotyping by flow cytometry in which plasma cells accounted for 10% or more of the leukocytes by morphologic assessment of the diagnostic aspirate smears. The 30 cases selected for this study were obtained from 18 men and 12 women (mean age SD, 64 12; range, years). The research use of these materials was approved by the University of Utah institutional review board (No ) Morphologic Analysis All the original diagnostic material, including Wright-stained bone marrow aspirate smears and paraffin-embedded, hematoxylin-eosin stained sections of bone marrow cores, were reviewed. The morphologically determined plasma cell values from the diagnostic aspirate smears were based on counts of 500 nucleated cells. In 28 of 30 cases, the percentages of plasma cells listed on the original surgical pathology reports appeared to be accurate on the basis of inspection of the core biopsy specimens and aspirate smears and were used for this study (after correction to exclude red blood precursors see below). In 2 cases, however, the plasma cell values appeared different from those listed on the reports and were obtained from recounting 500 cells on the aspirate smears by all 3 authors; an average value was used. Percentages of plasma cells from smears prepared from samples sent to the flow cytometry laboratory were determined from leukocyte counts of 100 to 300 cells by one of the authors from direct smears made before red cell lysis. However, in 2 cases with suboptimal flow cytometry smears, plasma cell counts were performed by all authors, with the average of the 3 values being used. Because red blood cell precursors are not usually identified by flow cytometry, all morphologically determined plasma cell percentages were expressed as a percentage of total leukocytes to facilitate comparison. Flow Cytometric Analysis Routine flow cytometric immunophenotyping studies were performed on all cases at the time of diagnosis, as described elsewhere. 10 More specifically, erythrocytes and erythrocyte precursors in the bone marrow specimens were lysed by incubating at 37 C for 10 minutes in a 10-fold excess of ammonium chloride (0.15M with 0.01M sodium bicarbonate and 0.1M disodium EDTA). Following centrifugation (for 5 minutes at 400g), liquid was removed by decanting and blotting (procedure following all centrifugation steps). The leukocytes were manually resuspended by using a plastic bulbed pipette, washed with 15 ml Roswell Park Memorial Institute (RPMI) medium 1% bovine serum albumin (BSA), and resuspended with a plastic bulbed pipette in 2 ml RPMI medium 1% BSA. For surface staining, 10 L or20 L of antibodies was added to approximately 1 million leukocytes in 100 L of RPMI medium 1% BSA. All antibodies were used as recommended by the supplier and were directly conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE), or PE-cyanine 5 (PC5). Following incubation for 15 minutes at room temperature in the dark, cells were washed with 3 ml phosphate-buffered saline (PBS) and resuspended in 0.5 ml 0.5% paraformaldehyde before analysis by gently running the tubes over an empty tube rack (procedure used for all subsequent resuspension steps). Cytoplasmic staining was performed by using the IntraPrep permeabilization reagents according to the manufacturer s directions (Beckman Coulter, Miami, Fla). More specifically, approximately 1 million erythrocyte-depleted leukocytes were incubated in 100 L of fixative solution at room temperature for 15 minutes in the dark, washed with 3 ml of PBS, and resuspended in 100 L of permeabilization solution. After 5 minutes, 10 L or20 L of antibodies was added and washed with 3 ml of PBS following 15 minutes of incubation in the dark, and resuspended in 0.5 ml of 0.5% paraformaldehyde before analysis. Data acquisition and analysis were performed with an EPICS XL cytometer and EXPO 32 software (Beckman Coulter). Antibodies used to identify plasma cells included anti-cd38 PE (Leu- 17), anti-cd56 FITC (NCAM16.1), anti- FITC (TB28-2), and anti- PE ( ), purchased from BD Biosciences (San Jose, Calif), along with anti-cd45 PC5 (HI30), purchased from Caltag Laboratories (Burlingame, Calif). Plasma cell quantitation was performed by surface staining (using the combination of CD56 FITC/CD38 PE/CD45 PC5) and by cytoplasmic staining (using the combination of FITC/ PE/CD45 PC5. With use of our procedure, plasma cells displayed cytoplasmic light-chain levels 1 to 2 log higher than mature B cells. Flow cytometric plasma cell percentages were determined by quantitating those cells with dim to negative CD45 that had bright (fourth decade) surface expression of CD38. Plasma cell percentages were also determined by quantitating cells with bright cytoplasmic light-chain expression that were usually located in the CD45 dim to negative gate. Ungated histograms were reviewed in all cases to ensure that rare neoplastic plasma cells that may express CD45 could also be detected. An average of these 2 flow cytometry derived plasma cell values was used, but in all cases these methods gave values within 10% or less of one another. RESULTS Percentages of plasma cells were determined morphologically and by flow cytometry for the 30 cases (Figures 1 and 2). The flow cytometry determined plasma cell percentages were typically markedly lower that those determined morphologically from the diagnostic aspirate specimens (mean difference SD, 78% 20%; mean foldreduction, 10 10), with only 2 cases (cases 17 and 18) showing similar, but still slightly lower, values by flow cytometry (Table; Figure 3, A). Morphologic analysis indicated that the specimens submitted for flow cytometry usually had markedly reduced plasma cell percentages relative to the diagnostic aspirate specimens (mean difference SD, 69% 28%; mean fold-reduction, 9 14), with only 3 cases having similar values (cases 17, 18, and 24). Plasma cell percentages determined by flow cytometry correlated better with morphologically determined plasma cell percentages in the flow cytometry specimens (Figure 3, B), although many of the flow cytometry values were low. Of the 11 cases with 10% or more morphologically determined plasma cells in the flow cytometry specimens, 5 had values similar to the flow percentages, whereas 6 had markedly lower plasma cell percentages by flow cytometry (mean difference SD, 48% 16%; mean foldreduction, 2 1). COMMENT It is commonly assumed that the accuracy of flow cytometry in quantitating plasma cell numbers in bone marrow aspirates may be problematic because of hemodilution or increased plasma cell fragility relative to other leukocytes that are typically present. 9 However, to our knowledge, studies that specifically address the accuracy of routine flow cytometric immunophenotyping in quantitating marrow aspirate plasma cell values have not yet been published. In this study, we document the frequency and magnitude by which plasma cell percentages determined by flow cytometry typically underestimate percentages determined morphologically from diagnostic aspirate 952 Arch Pathol Lab Med Vol 131, June 2007 Flow Cytometric Plasma Cell Quantitation Smock et al
3 Figure 1. Analysis of plasma cells by 3-color flow cytometry. Most cells with dim to negative expression of CD45 (A) are plasma cells that express bright monoclonal cytoplasmic light chains (B) and bright surface CD38 (C) (this case also expressed surface CD56). Figure 2. Morphologic quantitation of plasma cells. A, The core biopsy specimen contained sheets of plasma cells (hematoxylin-eosin, original magnification 400). B, The diagnostic aspirate smear contained 77% plasma cells (hematoxylin-eosin, original magnification 400). C, The flow cytometry aspirate contained 11% morphologically determined plasma cells (hematoxylin-eosin, original magnification 400). smears. In addition, our data also support the hypothesis that the process of performing flow cytometric immunophenotyping may also reduce plasma cell numbers in some cases. Based on morphologic analysis of the flow cytometry specimens, most of the underestimation of plasma cell percentages by flow cytometry appears to be due to hemodilution or poorer quality of the flow cytometry specimens compared with the aspirate smears used for diagnosis. At our institution and most others, the aspirate material used to make smears for diagnostic morphologic evaluation is obtained before any others and is often designated as first pull. Aspirate material obtained for ancillary studies, such as flow cytometry, is typically obtained from later aspirations or pulls and can often be of poor quality and nonrepresentative because fewer marrow cells were aspirated and/or substantial peripheral blood contamination was present. An interesting finding from our study was the large magnitude of this factor (mean percentage difference, 69% 28%), with some flow cytometry specimens having almost no morphologically detectable plasma cells and diagnostic smears having abundant plasma cells above 30%. In only 10% of cases were the morphologically determined plasma cell percentages in the flow cytometry specimens similar to the diagnostic aspirate smears. Flow cytometrically determined plasma cell percentages correlated better with the morphologically determined plasma cell percentages from the specimens submitted for flow cytometric analysis. However, in the 11 cases containing more than 10% plasma cells by morphologic analysis of the flow cytometry specimens, which represent more reliable values, slightly more than half (6/11) had markedly lower plasma cell values by flow cytometry (mean difference, 48% 16%; range, 36% 76%). These data support the common assumption that the process of performing routine flow cytometric immunophenotyping also contributes to reduction of reported plasma cell values in many cases. The mechanism whereby plasma cells are sometimes depleted by routine flow cytometric immunophenotyping is unclear but in our cases did not appear to be related to differences in specimen viability or specimen age. Perhaps the malignant plasma cells in some cases are more susceptible to ammonium chloride lysis than others or are less able to survive resuspension after centrifugation. Others have reported that ammonium chloride leaves the greatest number of plasma cells intact relative to other processing agents or methods, 11 and this method is also used for sensitive nonroutine flow cytometric tests that reportedly can detect 1 plasma cell in leukocytes. 8 However, few if any data have been published concerning loss of plasma cells related to specimen processing, and ammonium chloride may decrease the expression levels of some antigens, such as CD138, that are sometimes used to identify plasma cells by flow cytometry. 12 It appears, therefore, that additional study of this issue is warranted. Our data suggest that there are several reasons why Arch Pathol Lab Med Vol 131, June 2007 Flow Cytometric Plasma Cell Quantitation Smock et al 953
4 Figure 3. Comparisons of morphologic and flow cytometry determined plasma cell percentages. A, Diagnostic aspirate smear versus flow cytometric analysis. B, Flow cytometry specimen versus flow cytometric analysis. routine flow cytometric immunophenotyping studies are unlikely to generate accurate plasma cell percentage values in most cases, including differences in plasma cell content between samples submitted for morphologic review and samples submitted for flow cytometry, and plasma cell loss during flow cytometry sample processing steps. Although we used only 3-color analysis to identify plasma cells and did not use antibodies against CD138, it is unlikely that substantial numbers of plasma cells were missed because of this technical approach. Our method of Comparison of Different Plasma Cell Percentages* Case No. Morphologic Analysis, % Diagnostic Aspirate Smear Flow Cytometry Specimen Flow Cytometric Analysis, % Mean SD (range) (12 77) (1 70) (0 33) * Values are the percentages of leukocytes. identifying plasma cells as those cells with dim to negative expression of CD45 that also expressed bright CD38 is used by other laboratories, 6 and also gave excellent agreement with the percentages of plasma cells independently determined by quantitating cells that expressed bright monoclonal cytoplasmic light chains. Moreover, our analysis of cytoplasmic light-chain expression can also easily identify plasma cells that may express CD45, although all the cases in this study were CD45 negative. In addition, variable expression of CD138 on plasma cells has been reported, 13,14 and most participants in an international flow cytometry consensus meeting felt that the use of CD138 was not essential in identifying plasma cells, whereas the markers we evaluated (cytoplasmic light chains, CD38, CD45) were the most important. 15 In conclusion, this study provides considerable evidence that routine flow cytometric immunophenotyping is not a good method for generating accurate bone marrow plasma cell load values. Moreover, the large discrepancies between morphologically determined plasma cell values of the diagnostic aspirates and the flow cytometry determined values suggest that flow cytometry may also easily miss plasma cell neoplasms in many cases unless antibodies specific for plasma cell identification are requested or relevant history is provided. Although flow cytometry typically underestimates the bone marrow plasma cell load, it appears to provide a lower limit estimate and is also useful in distinguishing between normal and malignant plasma cells, which can be very important in evaluating posttreatment follow-up specimens for residual disease. We thank Ms Jackie McCowen-Rose for her help in producing Figure 1. References 1. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; World Health Organization Classification of Tumours. 2. Wei A, Juneja S. Bone marrow immunohistology of plasma cell neoplasms. J Clin Pathol. 2003;56: Sukpanichnant S, Cousar JB, Leelasiri A, Graber SE, Greer JP, Collins RD. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation. Hum Pathol. 1994;25: Chilosi M, Adami F, Lestani M, et al. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol. 1999;12: O Connell FP, Pinkus JL, Pinkus GS. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am J Clin Pathol. 2004;121: Arch Pathol Lab Med Vol 131, June 2007 Flow Cytometric Plasma Cell Quantitation Smock et al
5 6. Nowakowski GS, Witzig TE, Dingli D, et al. Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma. Blood. 2005;106: van Zaanen HC, Vet RJ, de Jong CM, von dem Borne AE, van Oers MH. A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using flowcytometry. Br J Haematol. 1995;91: Rawstron AC, Davies FE, DasGupta R, et al. Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood. 2002;100: Braylan RC. Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasias. Cytometry A. 2004;58: Newell JO, Cessna MH, Greenwood J, Hartung L, Bahler DW. Importance of CD117 in the evaluation of acute leukemias by flow cytometry. Cytometry. 2003;52B: Lin P, Owens R, Tricot G, Wilson CS. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol. 2004;121: Witzig TE, Kimlinger T, Stenson M, Therneau T. Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia. Leuk Lymphoma. 1998;31: Bayer-Garner IB, Sanderson RD, Dhodapkar MV, Owens RB, Wilson CS. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Mod Pathol. 2001;14: Rawstron AC, Owen RG, Davies FE, et al. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol. 1997;97: Braylan RC, Orfao A, Borowitz MJ, Davis BH. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. Cytometry. 2001;46: Arch Pathol Lab Med Vol 131, June 2007 Flow Cytometric Plasma Cell Quantitation Smock et al 955
Single Tube, Six-Color Flow Cytometric Analysis Is a Sensitive and Cost-Effective Technique for Assaying Clonal Plasma Cells
Hematopathology / Flow Cytometric Analysis of Clonal Plasma Cells Single Tube, Six-Color Flow Cytometric Analysis Is a Sensitive and Cost-Effective Technique for Assaying Clonal Plasma Cells Derek K. Marsee,
More informationImmunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry *Akanni EO and # Palini A.
Immunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry *Akanni EO and # Palini A. * Department of Haematology & Blood Transfusion,College of Health Science, Ladoke Akintola University
More informationFlow Cytometric Immunophenotypic Analysis of 306 Cases of Multiple Myeloma
Hematopathology / PLASMA CELL IMMUNOPHENOTYPING Flow Cytometric Immunophenotypic Analysis of 36 Cases of Multiple Myeloma Pei Lin, MD, 1* Rebecca Owens, 1 Guido Tricot, MD, PhD, 2 and Carla S. Wilson,
More informationTechnical Note: A Counting Strategy for Estimating Plasma Cell Number in CD138-Stained Bone Marrow Core Biopsy Sections
Available online at www.annclinlabsci.org 138 Technical Note: A Counting Strategy for Estimating Plasma Cell Number in CD138-Stained Bone Marrow Core Biopsy Sections Fred B. Smith and Ashraf Elnawawi Department
More informationProposals of B cells standard immunophenotyping in mature B cell non-hodgkin lymphomas
Clinical immunology Proposals of B cells standard immunophenotyping in mature B cell non-hodgkin lymphomas URSZULA PODSTAWKA, IZABELLA SZCZEPAŃSKA, JOANNA KOPEĆ-SZLĘZAK Department of Hematological Cytobiology,
More informationRef: CYT-MM-MRD. For Research Use Only. Not for use in diagnostic procedures
Ref: CYT-MM-MRD For Research Use Only. Not for use in diagnostic procedures MM MRD VIALS AND COMPENSATION TUBES ARE LYOPHILIZED PRODUCTS. READ CAREFULLY THE FOLLOWING INSTRUCTIONS FOR RECONSTITUTION: The
More informationBIMM18 Dec 20 th - Flow cytometry in clinical diagnostics
BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics I. B cell leukemia and lymphomas Immunophenotyping as part of the diagnostic work- up of hematologic malignancies offers a rapid and effective
More informationCLEARLLAB LS LYMPHOID SCREEN REAGENT
CLEARLLAB LS LYMPHOID SCREEN REAGENT CE MARKED ANTIBODY COMBINATION FOR LEUKEMIA / LYMPHOMA ANALYSIS Because Your Patient is Her Everything BECAUSE YOUR PATIENT IS HER EVERYTHING ClearLLab LS Lymphoid
More informationFlow Cytometry in the Diagnosis of Hematopoietic Neoplasia. Brent Wood MD, PhD Professor, Laboratory Medicine University of Washington, Seattle
Flow Cytometry in the Diagnosis of Hematopoietic Neoplasia Brent Wood MD, PhD Professor, Laboratory Medicine University of Washington, Seattle 1 Flow Cytometer 2 The Power of Flow Cytometry Single cell
More informationGuidelines for the diagnosis of Multiple Myeloma Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology
Guidelines for the diagnosis of Multiple Myeloma 2014 By:British Committee for Standards in Haematology (BCSH) Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology Diagnosis, prognostic factors and disease monitoring
More informationMinimum Information about a Flow Cytometry Experiment (MIFlowCyt) Annotation
Minimum Information about a Flow Cytometry Experiment (MIFlowCyt) Annotation 1. Experiment Overview 1.1 Purpose The purpose of these sets of experiments is to develop a methodology of identifying and quantifying
More informationCD22 (S-HCL-1) IVD. Table 1 Bottling concentrations. Monoclonal mouse anti-human reagent for identification of cells expressing CD22 antigen
2/2014 23-6995-02 IVD CD22 (S-HCL-1) Monoclonal mouse anti-human reagent for identification of cells expressing CD22 antigen Form Catalog No. FITC 337898 PE 337899 APC 333145 BD, BD Logo and all other
More informationINTENDED PURPOSE. TECHNICAL SUMMARY.
Product: FITC Anti-Human CD2 Cat. Ref: 2F-100T Reagent provided: 100 test (20μl/test) Description: Mouse Monoclonal Anti-Human CD2 FITC is recommended for use in flow cytometry for identification of peripheral
More informationPRINCIPLES OF THE PROCEDURE
CD19 For In Vitro Diagnostic use Fluorochrome Reference Clon Isotype Format µl/test FITC CYT-19F6 HIB19 IgG1 1 ml/200 test 5 PerCP-Cyanine5.5 CYT-19C8 HIB19 IgG1 150ul/50 test 3 PE-Cyanine5 CYT-19C3 HIB19
More informationLambda-APC-C750 Ref: CYT-LAC750
Lambda-APC-C750 Ref: CYT-LAC750 For In Vitro Diagnostic use INTENDED USE Lambda-APC-C750 is a polyclonal antibody (pab) labelled with the tandem allophycocyanine-c750 (APC- C750) and designed for use as
More informationJune Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD
June 2011 Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD In this issue we review the laboratory work up of patients suspected of having a plasma cell neoplasm. As the range in clinical
More informationAn approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/ lambda ratios of CD38-gated CD138 + cells
Nakayama et al. Diagnostic Pathology 2012, 7:131 RESEARCH Open Access An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/ lambda ratios of CD38-gated CD138 + cells
More informationKey terms: flow cytometry; reagents; reporting; consensus; optimal
Cytometry Part B (Clinical Cytometry) 72B:S14 S22 (2007) 2006 Bethesda International Consensus Recommendations on the Immunophenotypic Analysis of Hematolymphoid Neoplasia by Flow Cytometry: Optimal Reagents
More informationBD IMag. Streptavidin Particles Plus - DM. Technical Data Sheet. Product Information
Technical Data Sheet Streptavidin Particles Plus - DM Product Information Material Number: Size: Storage Buffer: 557812 5 ml Aqueous buffered solution containing BSA and 0.09% sodium azide. Description
More informationRPCI 001 v.003 In vitro Intracellular Cytokine Staining With and Without Stimulation
Immune Tolerance Network RPCI 001 v.003 Author: Paul Wallace and Earl Timm, Director, RPCI Laboratory of Flow Cytometry Approved by: Paul Wallace, Director, RPCI Laboratory of Flow Cytometry 1.0 Title
More informationCME/SAM. Limited Flow Cytometry Panels on Bone Marrow Specimens Reduce Costs and Predict Negative Cytogenetics
Limited Flow Cytometry Panels on Bone Marrow Specimens Reduce Costs and Predict Negative Cytogenetics Douglas G. Hoffmann, MD, and Burton H. Kim, MD From the Department of Pathology, Wellstar Health System,
More informationPractical Guidelines and Tips for Sensitive and Accurate Identification of PNH Clones
Practical Guidelines and Tips for Sensitive and Accurate Identification of PNH Clones AFCG Meeting Nov 28 Dec 1, 2013 Wellington, New Zealand Andrea Illingworth, MS, H(ASCP), QCYM Dahl-Chase Diagnostic
More informationLABORATORY ASSESSMENT OF HAEMATOLOGY ONCOLOGY IMMUNOPHENOTYPING. First Edition Australasian Cytometry Society Laboratory Assessment Document
LABORATORY ASSESSMENT OF HAEMATOLOGY ONCOLOGY IMMUNOPHENOTYPING First Edition 2018 Australasian Cytometry Society Laboratory Assessment Document Paper-based publications This work is copyright. You may
More informationRuud Hulspas, Mike Keeney, Ben Hedley and Andrea Illingworth
Sponsored and reviewed by ICCS Quality and Standards Committee Title: Quality of Reagents Monoclonal Antibodies Written by: Date: March 6, 2018 Ruud Hulspas, Mike Keeney, Ben Hedley and Andrea Illingworth
More information2. SUMMARY AND EXPLANATION
English Stem-Trol Control Cells 1-10 1. INTENDED USE 2 2. SUMMARY AND EXPLANATION 2 3. PRINCIPLE OF TEST 2 4. REAGENT CONTENTS 2 5. STATEMENT OF WARNINGS 2 6. STORAGE CONDITIONS AND STABILITY 3 6.1 Evidence
More informationStandardization of Minimal Residual Disease Testing in Multiple Myeloma
Standardization of Minimal Residual Disease Testing in Multiple Myeloma Linda B. Baughn 1 and Michael A. Linden 2 * Multiple myeloma (MM) 3 is an incurable neoplasm of the bone marrow characterized by
More informationValidation of Platelet Counting Accuracy With the Celltac F Automated Hematology Analyzer
Journal of Automated Methods & Management in Chemistry, 5 (5), no. 4, 35 39 c 5 Hindawi Publishing Corporation Validation of Platelet ing Accuracy With the Celltac F Automated Hematology Analyzer Yutaka
More informationNeutrophil/Monocyte Respiratory Burst Assay Kit
Neutrophil/Monocyte Respiratory Burst Assay Kit Item No. 601130 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: flow_cytometry 1/1/2019 N/A 1/1/2020 1/1/2019 Policy Effective April 1, 2019 Description of Procedure or
More informationIdentification of red and white blood cells from whole blood samples using the Agilent 2100 bioanalyzer. Application Note
Identification of red and white blood cells from whole blood samples using the Agilent 2100 bioanalyzer Application Note Sylvie Veriac Valérie Perrone Madeleine Avon Abstract Agilent Equipment: 2100 bioanalyzer
More informationIn vivo BrdU Incorporation Assay for Murine Hematopioetic Stem Cells Ningfei An, Yubin Kang *
In vivo BrdU Incorporation Assay for Murine Hematopioetic Stem Cells Ningfei An, Yubin Kang * Division of Hematology-Oncology, Department of Medicine, Medical University of South Carolina, Charleston,
More informationHigh-dimensional flow-cytometric analysis of human B-cell populations
High-dimensional flow-cytometric analysis of human B-cell populations The BD FACSCelesta cell analyzer and FlowJo software together enable deep analysis of B-cell biology Features High-resolution analysis
More informationBD IntraSure Kit IVD. Cell fixation and permeabilization reagents. 50 tests per kit Catalog No
03/2015 23-8992-01 IVD BD IntraSure Kit Cell fixation and permeabilization reagents 50 tests per kit Catalog No. 641778 BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company.
More informationAnti-Lambda ( )
Anti-Lambda (1-155-2) Monoclonal mouse anti-human reagent for identification of cells expressing lambda light chains 10/2013 23-5590-03 IVD Form Catalog No. FITC 347247 PE 642925 Not for sale in the US
More informationACTG Laboratory Technology Committee Version 1.0 ACTG Lab Man Dye Dilution (CFSE) Proliferation 12 April 2004
LYMPHOCYTE PROLIFERATION USING SUCCINIMIDYL ESTER OF CARBOXYFLIORESCEIN DIACETATE 1. PRINCIPLE: The succinimidyl ester of carboxyfluorsecein diacetate [5(6)]- CFSE is the best reagent currently available
More informationEDUCATIONAL COMMENTARY LABORATORY EVALUATION OF IMMUNOPROLIFERATIVE DISORDERS
Commentary provided by: Louann W. Lawrence, Dr.PH, MLS (ASCP) Professor Emeritus, Retired Louisiana State University Health Sciences Center New Orleans, LA EDUCATIONAL COMMENTARY LABORATORY EVALUATION
More informationCOMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT EasySep Direct Human Total Lymphocyte Isolation Cocktail for RoboSep
This document is available at www.stemcell.com/pis Catalog #9655 EasySep Direct Human Total Lymphocyte Isolation Kit For processing 00 ml whole blood Description Isolate highly purified lymphocytes directly
More informationProtocol to detect N-Glycolylneuraminic acid (Neu5Gc) using Flow Cytometry Analysis.
Page 1 of 5 Protocol to detect N-Glycolylneuraminic acid (Neu5Gc) using Flow Cytometry Analysis. The Gc-Free Basic Pack may be used for immuno-staining cells prior to analysis by Flow Cytometry. This Basic
More informationInstability of Immunophenotype in Plasma Cell Myeloma
Hematopathology / Instability of Immunophenotype in PCM Instability of Immunophenotype in Plasma Cell Myeloma Wenqing Cao, MD, 1 Charles L. Goolsby, PhD, 1 Beverly P. Nelson, MD, 1 Seema Singhal, MD, 2
More informationBD Stabilizing Fixative
BD Stabilizing Fixative 04/2015 23-7725-05 IVD 3X concentrate Catalog No. 339860 BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. 2015 BD Becton, Dickinson and Company
More informationa Beckman Coulter Life Sciences: White Paper
a Beckman Coulter Life Sciences: White Paper Flow Cytometric Analysis of Endothelial Progenitor Cells Authors: Affiliation: Dorota Sadowicz, Vasilis Toxavidis, John Tigges Beth Israel Deaconess Medical
More informationPERFECT-COUNT MICROSPHERES
PERFECT-COUNT MICROSPHERES Perfect-Count Microspheres-Product code PCB-100 for 100 tests Introduction In recent years, the determination of absolute cell counts has been shown to be relevant in different
More informationValidation of Platelet Counting Accuracy With the Celltac F Automated Hematology Analyzer
Automated Methods & Management in Chemistry, 25 (25), no. 4, 235 239 c 25 Validation of Platelet Counting Accuracy With the Celltac F Automated Hematology Analyzer Yutaka Nagai, 1 Hiroshi Kondo, 2 and
More informationTITLE: LIVE/DEAD VIABILITY FOR CLINICAL SAMPLES
Paul K. Wallace, Ph.D. Director Roswell Park Cancer Institute Elm & Carlton Streets Voice:(716) 845-8471 Buffalo, NY 14263 Fax:(716) 845-8806 FILE NAME FL-SRP-2090.00 Live/Dead Viability for Clinical Samples
More informationMRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods
REGULAR ARTICLE MRD detection in multiple myeloma: comparison between MSKCC 1-color single-tube and EuroFlow 8-color 2-tube methods Mikhail Roshal, 1 Juan A. Flores-Montero, 2-4 Qi Gao, 1 Maesa Koeber,
More informationDifferent Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin
Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin Carla Tripisciano 1, René Weiss 1, Tanja Eichhorn 1,
More informationThe NIAID Flow Cytometry Advisory Committee; the Guidelines Subcommittee
January, 1999 From: To: Subject: The NIAID Flow Cytometry Advisory Committee; the Guidelines Subcommittee NIAID DAIDS Flow Cytometry Laboratories Comparison study information for labs wishing to switch
More informationchronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma
Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart
More informationBringing the EuroFlow Concept
Bringing the EuroFlow Concept Cytognos - EuroFlow Supporting Company Company Overview Cytognos provides through worldwide distribution a broad range of reagents and software for flow cytometry applications
More informationApplication Note. Assay Portability on the BD FACSVerse System. Summary. Maria Jaimes, Yibing Wang, Catherine McIntyre, and Dev Mittar
September Assay Portability on the BD FACSVerse System Maria Jaimes, Yibing Wang, Catherine McIntyre, and Dev Mittar Contents Summary Introduction 3 Objective 4 Methods 6 Results Discussion Conclusions
More informationTECHNICAL BULLETIN. QUANTUM SIMPLY CELLULAR KIT Product Numbers QSC-20 AND QSC-100 Storage Temperature 2-8 C. Do Not Freeze
QUANTUM SIMPLY CELLULAR KIT Product Numbers QSC-20 AND QSC-100 Storage Temperature 2-8 C. Do Not Freeze TECHNICAL BULLETIN Product Description The Quantum Simply Cellular Kit provides a convenient method
More informationبسم اهلل الرمحن الرحيم
بسم اهلل الرمحن الرحيم Definition Multiple myeloma is a neoplastic plasma cell dyscrasia (PCD) that generally produced a monoclonal immunoglobulin protein, characterized by a clinical pentad: (a) anemia;
More informationCOMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze.
This document is available at www.stemcell.com/pis EasySep Mouse PE Kit II Catalog #17666 Catalog #17696 For processing 1 x 10^9 cells For processing 5 x 10^9 cells Description Isolate highly purified
More information1. INTENDED USE CD71 (L01.1) Form Catalog No. FITC APC Applications IVD 2. COMPOSITION Becton, Dickinson and Company BD Biosciences
2/2014 23-7076-02 IVD CD71 (L01.1) Monoclonal mouse anti-human reagent for identification of cells expressing CD71 antigen Form Catalog No. FITC 333151 APC 337447 BD, BD Logo and all other trademarks are
More information2111: ALL Post-HCT. Add/ Remove/ Modify. Manual Section. Date. Description. Comprehensive Disease- Specific Manuals
2111: ALL Post-HCT The Acute Lymphoblastic Leukemia Post-HCT Data Form is one of the Comprehensive Report Forms. This form captures ALL-specific post-hct data such as: planned treatments post-hct, the
More informationFlow cytometry has become an increasingly important
9-Color and 10-Color Flow Cytometry in the Clinical Laboratory Brent Wood, MD, PhD Context. The development of commercial flow cytometers capable of detecting more than 10 simultaneous fluorescent signals
More informationFCM immunophenotyping and DNA analysis: Practical aspects that can affect data analysis and interpretation
Preface Flow cytometry immunophenotyping of hematopoietic disorders is a complex and demanding exercise that requires a good understanding of cell lineages, developmental pathways, and physiological changes,
More informationHot Topic. Disclosures. None
Hot Topic Multiple Myeloma Testing at Mayo Medical Laboratories HOT TOPIC / 2017 MFMER 1 Our speaker for this program is Dragan Jevremovic, MD, PhD Assistant Professor, Division of Hematopathology at Mayo
More informationQuantiBRITE CD20 IVD. Monoclonal mouse anti-human reagent for identification of cells expressing CD20 antigen. Form Catalog No.
QuantiBRITE CD20 Monoclonal mouse anti-human reagent for identification of cells expressing CD20 antigen 8/2010 IVD Form Catalog No. PE 347220 Becton, Dickinson and Company BD Biosciences San Jose, CA
More informationACTG Laboratory Technologist Committee Revised Version 2.0 ACTG Lab Man CD38 Quantitation 07 May 2004
1. Principle Flow Cytometric quantitation of CD38 expression on CD8+ T lymphocytes The purpose of this assay is to quantitate the surface expression of the CD38 molecule on CD8 positive T lymphocytes.
More informationStem Cells and Multiple Myeloma
Stem Cells and Multiple Myeloma What is Multiple Myeloma Multiple Myeloma is a cancer of your plasma cells, a type of white blood cell present in your bone marrow Plasma cells normally make proteins called
More informationThe histopathology of myeloma in the bone marrow
Journal of clinical and experimental hematopathology Vol. 58 No.2, 61-67, 2018 JC lin EH xp ematopathol Review Article The histopathology of myeloma in the bone marrow Masahiko Fujino Myeloma is characterized
More informationCOMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze.
This document is available at www.stemcell.com/pis EasySep Mouse CD90. Kit II Catalog #89 For processing x 0^9 cells Description Isolate highly purified CD90.+ (Thy.+) cells from mouse splenocytes or other
More informationCOMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT RosetteSep Human Progenitor Cell Basic Pre-Enrichment Cocktail
This document is available at www.stemcell.com/pis Positive Selection Catalog #7897 EasySep Human Cord Blood CD Positive Selection For processing 000 ml of cord blood Description Isolate highly purified
More informationCOMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Do not freeze. Store at 2-8 C. Do not freeze. Store at 2-8 C.
This document is available at www.stemcell.com/pis Positive Selection Catalog #7896 EasySep Human Cord Blood CD3 Positive For processing 000 ml of cord blood Description Isolate highly purified CD3+ cells
More informationCOMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze.
This document is available at www.stemcell.com/pis EasySep Anti-Rat IgGa Kit Catalog #8990 For processing x 0^9 cells Description EasySep Anti-Rat IgGa Kit contains all of the necessary components to create
More informationTitration of Fluorochrome-Conjugated Antibodies for Labeling Cell Surface Markers on Live Cells
Titration of Fluorochrome-Conjugated Antibodies for Labeling Cell Surface Markers on Live Cells Ruud Hulspas 1 UNIT 6.29 1 Cytonome/ST, Boston, Massachusetts ABSTRACT Nonspecific antibody binding is best
More informationBD Multicolor CompBeads
4/2015 23-9955-01 IVD BD Multicolor CompBeads 100 compensation setups Catalog No. 644204 BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. 2015 BD Becton, Dickinson and
More informationApplication Information Bulletin: Set-Up of the CytoFLEX Set-Up of the CytoFLEX* for Extracellular Vesicle Measurement
Application Information Bulletin: Set-Up of the CytoFLEX Set-Up of the CytoFLEX* for Extracellular Vesicle Measurement Andreas Spittler, MD, Associate Professor for Pathophysiology, Medical University
More informationDetecting human circulating endothelial cells using the Attune Acoustic Focusing Cytometer
APPLICATION NOTE Attune Acoustic Focusing Cytometer Detecting human circulating endothelial cells using the Attune Acoustic Focusing Cytometer Circulating endothelial cells (CECs) are mature cells shed
More informationStore at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze.
Catalog #1086 Complete Kit for Human Whole Blood CD3+ Cells For labeling 120 ml of whole blood Description Isolate highly purified CD3 cells from human whole blood using a simple, two-step procedure. Fast
More informationInhibiScreen Kinase Inhibitor Assay
InhibiScreen Kinase Inhibitor Assay Flow Cytometric assessment of efficacy of PI3Kγ, PI3Kδ, BTK and SYK pathway inhibitors using the measurement of basophil activation in human EDTA and Heparin Whole Blood.
More information18/08/2011. Principles of Flow Cytometry (Practised in a Clinical Laboratory) Cytometer Components. Noel Williams Immunobiology Division of Immunology
Optical Measurement Principles Principles of Flow Cytometry (Practised in a Clinical Laboratory) Noel Williams Immunobiology Division of Immunology Cytometer Components Reagents Cytometer Setup Cytometer
More informationab pdc Subset Phenotyping Kit
ab177772 pdc Subset Phenotyping Kit Instructions for Use A set of antibodies designed to identify pdcs and subsets of pdcs by multi-color flow cytometry. This product is for research use only and is not
More informationCOMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Store at 2-8 C. Do not freeze. Store at 2-8 C. Do not freeze.
This document is available at www.stemcell.com/pis Positive Selection Catalog #7896 EasySep Human Cord Blood CD Positive For processing 000 ml of cord blood Description Isolate highly purified CD+ cells
More informationQuantification of Surface Antigens and Quantitative Flow Cytometry
5 Quantification of Surface Antigens and Quantitative Flow Cytometry Huai En Huang Chan, Iman Jilani, Richard Chang, and Maher Albitar Summary Measuring expression levels of cell surface antigens is important
More informationPCCS Growth Media, Cell Tagging, Cell Separation Final Assignment. Igneris Rosado-Erazo. Panama College of Cell Science
Running Head: Growth Media, Cell Tagging, Cell Separation PCCS Growth Media, Cell Tagging, Cell Separation Final Assignment Igneris Rosado-Erazo Panama College of Cell Science In partial fulfillment of
More informationImmunophenotyping UNIT
Immunophenotyping UNIT 6.2 There are four basic methods for staining cells with antibodies for immunophenotyping by flow cytometry. The first method (see Basic Protocol 1) is an indirect one that employs
More informationClinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
T h e n e w e ng l a nd j o u r na l o f m e dic i n e original article Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma Robert A. Kyle, M.D., Ellen D. Remstein, M.D., Terry
More informationEdU Click FC ROTI kit for Flow Cytometry
USER MANUAL EdU Click FC EdU Click FC Introduction and product description: The detection of cell proliferation is of utmost importance for assessing cell health, determining genotoxicity or evaluating
More informationSuppression of Polyclonal Immunoglobulin Production by M-proteins Shows Isotype Specificity
274 Annals of Clinical & Laboratory Science, vol. 31, no. 3, 2001 Suppression of Polyclonal Immunoglobulin Production by M-proteins Shows Isotype Specificity Liang Wang and David C. Young Department of
More informationABSTRACT. From the Department of Medical Oncology, Cukurova University, Faculty of Medicine, Balcali Hospital, Yuregir, Adana, Turkey.
Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients Ismail O. Kara, MD, Berksoy
More informationEdU Flow Cytometry Kit. User Manual
User Manual Ordering information: (for detailed kit content see Table 2) EdU Flow Cytometry Kits for 50 assays: Product number EdU Used fluorescent dye BCK-FC488-50 10 mg 6-FAM Azide BCK-FC555-50 10 mg
More informationAmendment to ALL IC-BFM 2009 Standard Operating Procedure. 6-color FLOW-MRD detection in ALL
Amendment to ALL IC-BFM 2009 Standard Operating Procedure 6-color FLOW-MRD detection in ALL Version June 2014 M.N. Dworzak/J. Kappelmayer ALL IC-BFM 2009 FLOW-MRD SOP amendment June 2014 page 1 Marker
More informationAugust 2017 Changes. Flow Cytometry Checklist. CAP Accreditation Program
August 2017 Changes Flow Cytometry Checklist CAP Accreditation Program College of American Pathologists 325 Waukegan Road Northfield, IL 60093-2750 www.cap.org 08.21.2017 Disclaimer and Copyright Notice
More informationStrategies for Assessment of Immunotoxicology in Preclinical Drug Development
Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Rebecca Brunette, PhD Scientist, Analytical Biology SNBL USA Preclinical Immunotoxicology The study of evaluating adverse effects
More informationWhat do you do, with an M protein?
What do you do, with an M protein? Cancer Day for Primary Care Emily Rimmer MD FRCPC January 31, 2014 emily.rimmer@cancercare.mb.ca Disclosure of Potential for Conflict of Interest Name of presenter: Emily
More informationCOMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT RosetteSep Human Hematopoietic Progenitor Cell Enrichment Cocktail
This document is available at www.stemcell.com/pis Complete Kit for Human Whole Blood CD+ Cells Catalog #1086 For processing 120 ml whole blood Description Isolate highly purified CD cells from human whole
More informationReduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method
Coagulation and Transfusion Medicine / REDUCTION OF THE PLTELET REVIEW RTE Reduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method Deanne H. Chapman, MT(SCP)SH, 1 Jonn Hardin, MT,
More informationCD7 (M-T701) IVD. Antibody purity is as follows. FITC: 5% free fluorophore at bottling, as measured by size-exclusion chromatography (SEC)
8/2013 23-6905-02 IVD CD7 (M-T701) Monoclonal mouse anti-human reagent for identification of cells expressing CD7 antigen Form Catalog No. FITC 332773 PE 332774 BD, BD Logo and all other trademarks are
More informationMultiple myeloma (MM) & related disorders
Multiple myeloma (MM) & related disorders Plasma cell neoplasms Six major variants: (1) Multiple myeloma (2) Solitary plasmacytoma (3) Lymphoplasmacytic lymphoma They secrete a single complete or partial
More informationUse of an Automated Hematology Analyzer and Flow Cytometry to Assess Bone Marrow Cellularity and Differential Cell Count
Annals of Clinical & Laboratory Science, vol. 34, no. 3, 2004 307 Use of an Automated Hematology Analyzer and Flow Cytometry to Assess Bone Marrow Cellularity and Differential Cell Count Myungshin Kim,
More informationSupplementary File 3: DNA and RNA isolation
Supplementary File 3: DNA and RNA isolation Q-CROC-02 Biopsy protocol For the purposes of this protocol, four needle core biopsies (NCBs) of lymph node tissue are isolated from each patient using a 16G
More informationchronic leukemia lymphoma myeloma differentiated 14 September 1999 Pr e- Transformed Ig Su rf ace Su rf ace Secre ted Myelom a
Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pr e- B-ce ll B-ce ll Transformed B-ce ll Plasma cell Ig Su rf ace Su rf ace Secre ted Major malignant
More informationFor the removal or isolation of CD45 expressing cells via a negative or positive selection principle.
PlusCellect Human CD45 Kit Catalog Number PLS1430 For the removal or isolation of CD45 expressing cells via a negative or positive selection principle. This kit contains sufficient reagents for 25 tests
More informationMethods Western blot analysis of plg Quantification of plasminogen accumulation by ELISA Immunohistochemical analysis
Methods Western blot analysis of plg Wild-type mice first received a standardized burn wound and then were intravenously administered 2 mg of human plg (Omnio AB, Umeå, Sweden). 24 hours after wounding
More informationab Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis
ab139418 Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis Instructions for Use To determine cell cycle status in tissue culture cell lines by measuring DNA content using a flow cytometer. This
More informationab Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis
ab139418 Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis Instructions for Use To determine cell cycle status in tissue culture cell lines by measuring DNA content using a flow cytometer. This
More informationManaging Specimen Stability for Robust Flow Cytometric Clinical Biomarker Assays
Managing Specimen Stability for Robust Flow Cytometric Clinical Biomarker Assays Dianna Wu, Richard Wnek Molecular Biomarkers & Diagnostics Merck Co., Inc 2014 AAPS Annual Meeting San Diego, CA (Fluorescent
More information